Deep learning for detecting and early predicting chronic obstructive pulmonary disease from spirogram time series.

Journal: NPJ systems biology and applications
PMID:

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung condition characterized by airflow obstruction. Current diagnostic methods primarily rely on identifying prominent features in spirometry (Volume-Flow time series) to detect COPD, but they are not adept at predicting future COPD risk based on subtle data patterns. In this study, we introduce a novel deep learning-based approach, DeepSpiro, aimed at the early prediction of future COPD risk. DeepSpiro consists of four key components: SpiroSmoother for stabilizing the Volume-Flow curve, SpiroEncoder for capturing volume variability-pattern through key patches of varying lengths, SpiroExplainer for integrating heterogeneous data and explaining predictions through volume attention, and SpiroPredictor for predicting the disease risk of undiagnosed high-risk patients based on key patch concavity, with prediction horizons of 1-5 years, or even longer. Evaluated on the UK Biobank dataset, DeepSpiro achieved an AUC of 0.8328 for COPD detection and demonstrated strong predictive performance for future COPD risk (p-value < 0.001). In summary, DeepSpiro can effectively predict the long-term progression of COPD disease.

Authors

  • Shuhao Mei
    Department of Computer Science, Tianjin University of Technology, Tianjin, China.
  • Xin Li
    Veterinary Diagnostic Center, Shanghai Animal Disease Control Center, Shanghai, China.
  • Yuxi Zhou
  • Jiahao Xu
    School of Ophthalmology and Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Yong Zhang
    Outpatient Department of Hepatitis, The Sixth Affiliated People's Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Yuxuan Wan
    Department of Computer Science, Tianjin University of Technology, Tianjin, China.
  • Shan Cao
    Shanghai Institute for Advanced Communication and Data Science, Shanghai University, Shanghai 200444, China.
  • Qinghao Zhao
    Department of Cardiology, Peking University People's Hospital, Beijing, China.
  • Shijia Geng
    HeartVoice Medical Technology, Hefei, 230027, China.
  • Junqing Xie
  • Shengyong Chen
  • Shenda Hong
    National Institute of Health Data Science at Peking University, Peking University, 100871 Beijing, China.